Group 1 - The core viewpoint of the news is that 嘉事堂's stock has experienced fluctuations, with a recent decline of 2.02% and a current price of 16.50 yuan per share, while the company has seen a year-to-date increase of 14.90% [1] - As of January 9, 嘉事堂's shareholder count has increased by 50% to 36,000, while the average circulating shares per person decreased by 33.33% to 8,096 shares [2] - 嘉事堂's main business involves pharmaceutical wholesale and retail, with commercial revenue accounting for 100% of its income [1] Group 2 - For the period from January to September 2025, 嘉事堂 reported a revenue of 14.459 billion yuan, representing a year-on-year decrease of 21.80%, and a net profit attributable to shareholders of 141 million yuan, down 38.81% year-on-year [2] - 嘉事堂 has been listed on the stock market since August 18, 2010, and has distributed a total of 874 million yuan in dividends since its A-share listing, with 216 million yuan distributed in the last three years [2] - The company operates within the pharmaceutical and biological industry, specifically in the pharmaceutical commercial sector, and is involved in various concept sectors including pharmaceutical e-commerce and state-owned enterprise reform [2]
嘉事堂跌2.02%,成交额1.10亿元,主力资金净流出1199.09万元